Redmile is an asset management group based in San Francisco.
Phone: 415-489-9980
One Letterman Drive
Building D, Suite D3-300
San Francisco, 94129
California, United States
| Date | Company | Round | Amount | Co-investors |
|---|---|---|---|---|
| 2018-09-12 | Atreca | Series C | $125M | Aisling Capital, Boxer Capital, Cormorant Asset Management, EcoR1 Capital, Samsara BioCapital, Tekla Capital Management, and Wellington Management |
| 2018-09-06 | OncoResponse | Series B | $40M | Alexandria Venture Investments, ARCH Venture Partners, Canaan Partners, GreatPoint Ventures, Helsinn Investment Fund, HT Family Office, Qatar Investment Authority, Rice University, and RiverVest Venture Partners |
| 2018-09-04 | Evox Therapeutics | Series B | $45M | Borealis Ventures, Cowen Group, Google Ventures, Oxford Sciences Innovation, Panacea Healthcare Solutions, and University of Oxford |
| 2018-06-06 | MedAvail Technologies | Unattributed VC | $12.66M | Adage Capital Management, Deerfield Management, Express Scripts, Lewis & Clark Ventures, and Pura Vida Investments |
| 2018-04-30 | Attenua | Series A | $35M | Abingworth, Omega Fund Management, and OrbiMed Advisors |
